Literature DB >> 27743713

Biliary atresia in Vietnam: Management and the burden of disease.

Max Bolun Liu1, Thuy Bui Huong2, Xuyen Hoang2, Lan Doan2, Shauna Trinh3, Hoa Pham Anh Nguyen2, Hai Thanh Le2, Ai-Xuan Holterman4.   

Abstract

BACKGROUND: Biliary atresia is an idiopathic, neonatal liver disease of the bile ducts. The natural evolution of biliary atresia is known in developed countries. This study describes the clinical course of biliary atresia in Vietnam, a developing country.
METHODS: Chart reviews were undertaken of patients treated with or without the Kasai procedure between January 2010 and July 2013 at a children's hospital in Vietnam.
RESULTS: Of 287 children with biliary atresia, 149 (52%) were treated without the Kasai procedure and 138 (48%) were treated with the Kasai procedure. Median age at diagnosis was 2.4 months for children treated without the Kasai procedure vs 2.3 months for those treated with the procedure. The percentages of patients in the group treated without the Kasai procedure presenting at <2 months, 2 to <3 months, 3 to <4 months, 4-6 months, and >6 months of age were 31%, 35%, 15%, 10%, and 9%, respectively, compared to those treated with the Kasai procedure at 36% (P = .38), 44% (P = .12), 16% (P = 1.0), 4% (P = .037), and 0% (P < .001), respectively. The group treated without the Kasai procedure had 1- and 2-year survivals of 52% and 28%, respectively (median survival 6.6 months); in contrast, the group treated with the Kasai procedure had 1- and 2-year transplant-free survivals of 84% and 71%. No patients were treated by liver transplantation because of lack of a liver transplantation program in Vietnam.
CONCLUSION: The majority of biliary atresia in Vietnam remains untreated despite early presentation and reasonable outcomes after a Kasai procedure relative to Western countries. These data illustrate the high health care burden for biliary atresia in Vietnam and the need to improve education about biliary atresia and its treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27743713     DOI: 10.1016/j.surg.2016.08.012

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Study protocol of Phase 2 open-label multicenter randomized controlled trial for granulocyte-colony stimulating factor (GCSF) in post-Kasai Type 3 biliary atresia.

Authors:  Hoa Pham Anh Nguyen; Jinma Ren; Marilyn Butler; Henri Li; Saqib Qazi; Kamran Sadiq; Hieu Trung Dao; AiXuan Holterman
Journal:  Pediatr Surg Int       Date:  2022-04-07       Impact factor: 1.827

2.  Chronic liver disease is universal in children with biliary atresia living with native liver.

Authors:  Way Seah Lee; Sik Yong Ong; Hee Wei Foo; Shin Yee Wong; Chen Xi Kong; Ru Bin Seah; Ruey Terng Ng
Journal:  World J Gastroenterol       Date:  2017-11-21       Impact factor: 5.742

3.  Novel findings from family-based exome sequencing for children with biliary atresia.

Authors:  Kien Trung Tran; Vinh Sy Le; Lan Thi Mai Dao; Huyen Khanh Nguyen; Anh Kieu Mai; Ha Thi Nguyen; Minh Duy Ngo; Quynh Anh Tran; Liem Thanh Nguyen
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

4.  Academic Pediatric Surgery Capacity Building in Vietnam Through PASS, a Pediatric Acute Surgical Support Course.

Authors:  Bich-Uyen Nguyen; Aixuan Holterman; Mark Holterman; Le-Thanh Dinh
Journal:  Front Surg       Date:  2022-04-20

5.  Long-Term Effects of Kasai Portoenterostomy for Biliary Atresia Treatment in Russia.

Authors:  Anna Degtyareva; Alexander Razumovskiy; Nadezhda Kulikova; Sergey Ratnikov; Elena Filippova; Ekaterina Gordeeva; Marina Albegova; Denis Rebrikov; Anna Puchkova
Journal:  Diagnostics (Basel)       Date:  2020-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.